Warning: Undefined array key "S1" in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Cisplatin.php on line 2
Cisplatin
LE WE PMID CA
Cisplatin553Cisplatin

Antineoplastic agents (Organometallic)

ATP7A

ATP7B

CD95 FAS Apo1

CDK2

Cisplatin

Ctr1

CTR2

Ear (Ototoxicity)

EIF2AK3 PERK

ERS UFR (Toxikologie)

HSP90

Interleukin24 MDA7

JNK

Kidney (Toxicology)

Lung and bronchial system (Neoplasia)

Transporter (Copper)

1979  
1
Cis-platinum: a new anticancer agent.
[380759] Br Med J 1(6179): 1689-91 (1979)
1993  
2
Review of platinum anticancer compounds.
[8258739] J Med 24(4-5): 209-65 (1993)
2008  
3
Novel Anticancer Platinum(IV) Complexes with Adamantylamine: Their Efficiency and Innovative Chemotherapy Strategies Modifying Lipid Metabolism.
[18414587] Met Based Drugs 2008(-): 417897 (2008)
2009  
4
Cisplatin ototoxicity and protection: clinical and experimental studies.
[19851045] Tohoku J Exp Med 219(3): 177-86 (2009)
2003  
5
Cisplatin and platinum drugs at the molecular level. (Review).
[14534679] Oncol Rep 10(6): 1663-82 (2003)
1993  
6
Cellular accumulation of the anticancer agent cisplatin: a review.
[8512802] Br J Cancer 67(6): 1171-6 (1993)
1992  
7
Modulation of cis-diamminedichloroplatinum(II) resistance: a review.
[1503895] Br J Cancer 66(2): 227-38 (1992)
2009  
8
Inhibition of transcription by platinum antitumor compounds.
[20046924] Metallomics 1(4): 280-91 (2009)
1994  
9
Cellular responses to cisplatin. The roles of DNA-binding proteins and DNA repair.
[8288625] J Biol Chem 269(2): 787-90 (1994)
1993  
10
Platinum resistance: laboratory findings and clinical implications.
[8318904] Stem Cells 11(3): 182-93 (1993)
2007  
11
Cisplatin nephropathy: is cytotoxicity avoidable?
[17617652] Nephrol Dial Transplant 22(8): 2112-6 (2007)
1997  
12
Insights into potential cellular mechanisms of cisplatin nephrotoxicity and their clinical application.
[9430835] Nephrol Dial Transplant 12(12): 2478-80 (1997)
2003  
13
New clues for platinum antitumor chemistry: kinetically controlled metal binding to DNA.
[12655051] Proc Natl Acad Sci U S A 100(7): 3611-6 (2003)
2003  
14
Nucleotide excision repair pathways involved in Cisplatin resistance in non-small-cell lung cancer.
[12915808] Cancer Control 10(4): 297-305 (2003)
2010  
15
Mechanisms of Cisplatin nephrotoxicity.
[22069563] Toxins (Basel) 2(11): 2490-518 (2010)
2010  
16
Cisplatin enhances protein kinase R-like endoplasmic reticulum kinase- and CD95-dependent melanoma differentiation-associated gene-7/interleukin-24-induced killing in ovarian carcinoma cells.
[19910452] Mol Pharmacol 77(2): 298-310 (2010)
2008  
17
Cytoplasmic initiation of cisplatin cytotoxicity.
[18400869] Am J Physiol Renal Physiol 295(1): F44-52 (2008)
2008  
18
Novobiocin and additional inhibitors of the Hsp90 C-terminal nucleotide-binding pocket.
[18991631] Curr Med Chem 15(26): 2702-17 (2008)
2010  
19
Copper transporters and the cellular pharmacology of the platinum-containing cancer drugs.
[20159940] Mol Pharmacol 77(6): 887-94 (2010)
2009  
20
Human copper transporters: mechanism, role in human diseases and therapeutic potential.
[20454597] Future Med Chem 1(6): 1125-42 (2009)
2009  
21
2008  
22
Regulation and pathological role of p53 in cisplatin nephrotoxicity.
[18682572] J Pharmacol Exp Ther 327(2): 300-7 (2008)
2010  
23
Specific hemosiderin deposition in spleen induced by a low dose of cisplatin: altered iron metabolism and its implication as an acute hemosiderin formation model.
[20540689] Curr Drug Metab 11(6): 507-15 (2010)

Downloaded from http://www.kidney.de - The Database of Free Medical Reviews - The Metatextbook of Medicine - Ossip Groth

All Medline data shown were primarily retrieved from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.


Fatal error: Uncaught Error: Call to undefined function mysql_connect() in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Cisplatin.php:92 Stack trace: #0 {main} thrown in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Cisplatin.php on line 92